D-Wave Quantum falls nearly 3% as earnings miss overshadows revenue beat
Investing.com -- LifeMD , Inc. (NASDAQ:LFMD) shares tumbled 29.5% after the virtual primary care provider reported second quarter results that missed analyst expectations and significantly lowered its full-year guidance due to challenges in its Rex MD business.
The telehealth company reported a second quarter loss of -$0.06 per share, worse than analysts’ expectations of -$0.02 per share. Revenue came in at $62.2 million, falling short of the $66.29 million consensus estimate, despite representing a 23% increase YoY. Telehealth revenue grew 30% to $48.6 million compared to the same period last year.
"Due to some temporary challenges facing our Rex MD business—which are now largely resolved—we are revising our full-year 2025 guidance for revenue and adjusted EBITDA to reflect the full-year impact of these issues," said Marc Benathen, LifeMD’s Chief Financial Officer.
The company slashed its full-year 2025 revenue guidance to $250-255 million from its previous forecast of $268-275 million, well below analyst expectations of $270.4 million. For the third quarter, LifeMD expects revenue between $61-63 million, also below the $67.7 million consensus.
Despite the disappointing results, LifeMD highlighted several positive developments, including a 16% increase in active telehealth subscribers to approximately 297,000 and improved adjusted EBITDA of $7.1 million compared to $2.2 million in the prior-year period.
"Our platform is undergoing a transformational expansion, broadening our clinical scope into some of the most pressing and underserved areas of healthcare," said Justin Schreiber, Chairman and CEO of LifeMD.
The company ended the quarter with $36.2 million in cash and has fully paid off all senior debt, strengthening its balance sheet despite the operational challenges.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.